FMC Corp (FMC)

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of FMC Corporation (NYSE: FMC) between November 16, 2023 and February 4, 2025. FMC describes itself as an “agricultural sciences company which develops, markets, and sells crop protection chemicals including insecticides, herbicides, and fungicides.”

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against FMC Corporation (“FMC” or the “Company”) (NYSE: FMC).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In FMC To Contact Him Directly To Discuss Their Options

NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of FMC Corporation (NYSE:FMC), TransMedics Group, Inc. (NASDAQ:TMDX), Intellia Therapeutics, Inc. (NASDAQ:NTLA), and Merck & Co., Inc. (NYSE: MRK). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) --

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In FMC To Contact Him Directly To Discuss Their Options

NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against FMC Corporation (“FMC” or the “Company”) (NYSE: FMC).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) --

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In FMC To Contact Him Directly To Discuss Their Options

SAN DIEGO, March 26, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired FMC Corporation (NYSE: FMC) securities between November 16, 2023 and February 4, 2025. FMC is an agricultural sciences company that develops, markets, and sells crop protection chemicals.

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against FMC Corporation (“FMC” or the “Company”) (NYSE:FMC).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of FMC Corporation (NYSE:FMC), TransMedics Group, Inc. (NASDAQ:TMDX), Alarum Technologies Ltd. (NASDAQ: ALAR), and Merck & Co., Inc. (NYSE: MRK). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) --

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of FMC Corporation (NYSE:FMC), Elastic N.V. (NYSE:ESTC), Intellia Therapeutics, Inc. (NASDAQ:NTLA), and Merck & Co., Inc. (NYSE: MRK). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of FMC Corporation (NYSE:FMC), Elastic N.V. (NYSE:ESTC), Intellia Therapeutics, Inc. (NASDAQ:NTLA), and Merck & Co., Inc. (NYSE: MRK). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired FMC Corporation (NYSE: FMC) securities between November 16, 2023 and February 4, 2025. FMC is an agricultural sciences company that develops, markets, and sells crop protection chemicals.

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against FMC Corporation (“FMC” or “the Company”) (NYSE: FMC) and certain of its officers.

NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of FMC Corporation (NYSE:FMC), TransMedics Group, Inc. (NASDAQ:TMDX), Alarum Technologies Ltd. (NASDAQ: ALAR), and Constellation Brands, Inc. (NYSE:STZ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) --

SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired FMC Corp. (NYSE: FMC) (“FMC” or the “Company”) securities between November 16, 2023 and February 4, 2025 (the “Class Period”), charging the Company and certain current and former senior executives with violations of the federal securities laws (collectively, “Defendants”).  

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against FMC Corporation (“FMC” or “the Company”) (NYSE: FMC) and certain of its officers.

Law Offices of Howard G. Smith reminds investors of the upcoming April 14, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) securities between November 16, 2023 and February 4, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against FMC Corporation (“FMC” or the “Company”) (NYSE:FMC) in the United States District Court for the Eastern District of Pennsylvania on behalf of all persons and entities who purchased or otherwise acquired FMC securities between November 16, 2023 and February 4, 2025, both dates inclusive (the “Class Period”). Investors have until April 14, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired FMC Corporation (NYSE: FMC) securities between November 16, 2023 and February 4, 2025. FMC is an agricultural sciences company that develops, markets, and sells crop protection chemicals.

Glancy Prongay & Murray LLP reminds investors of the upcoming April 14, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) securities between November 16, 2023 and February 4, 2025, inclusive (the “Class Period”).